#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thrombotic thrombocytopenic purpura Neuroendocrine tumour Small intestine leiomyosarcoma Neonatal alloimmune thrombocytopenia Fms-like tyrosine kinase 3 positive Pancreatic carcinoma Oesophageal squamous cell carcinoma Burkitt's lymphoma Huntington's disease Hepatoblastoma Central nervous system neoplasm Peripheral T-cell lymphoma unspecified Krabbe's disease Adrenocortical carcinoma Short-bowel syndrome More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Life with Disease Nodal marginal zone B-cell lymphoma – Life with Disease Small intestine leiomyosarcoma – Diagnostics Alveolar rhabdomyosarcoma – Diagnostics Pelizaeus-Merzbacher disease – Trials in Disease Soft tissue sarcoma – Basic Information Hepatoblastoma – Trials in Disease Carcinoid syndrome – Treatment Behcet’s syndrome – Basic Information Langerhans’ cell histiocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Morphine Hydrochloride Betaxolol Polatuzumab Vedotin Other Immunosuppressants Allopurinol Cefoxitin Guanabenz Acetate Obefazimod Thiamazole Indometacin PALAZESTRANT Mbf-118 Pyridoxine Hydrochloride Blomia Tropicalis RO7284755 Cdr132L ICOTROKINRA Tyra-300-B01 Riliprubart SOVATELTIDE More therapies…

    Learn about Your Condition

    Genital herpes Desmoid tumour Cold urticaria Herpes simplex meningitis Apathy Testis cancer Procedural hypotension Myotonic dystrophy Candida infection Wheezing Niemann-Pick disease Transplantation complication Arteriospasm coronary Oesophageal atresia Electronic cigarette user More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Intercommunal Le Raincy-Monfermeil…

Centre Hospitalier Intercommunal Le Raincy-Monfermeil

10 Rue Du General Leclerc, Monfermeil, 93370, France

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

    Recruiting

    2 1
    Investigated Drugs:
    • LY3537031
    France Germany The Netherlands Poland

  • Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

    Recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • ICOTROKINRA
    Belgium Czechia France Germany Greece Hungary +7

  • Study of icotrokinra for adults with moderately to severely active Crohn’s disease

    Recruiting

    4 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • ICOTROKINRA
    Belgium Czechia France Germany Greece Hungary +7

  • Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • SAR444336
    Belgium Denmark France Germany Hungary Italy +2

  • Study on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Omalizumab
    France

  • Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Cimetidine
    • Flecainide
    France

  • Study on the Effect of Genicular Arteries Embolization with Ioversol and Ethyl Esters of Iodised Fatty Acids in Patients with Symptomatic Knee Osteoarthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Ethyl Esters Of Iodised Fatty Acids From Poppyseed Oil
    • Heparin Sodium
    France

  • Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    France

  • Study of hydroxychloroquine with low-dose corticosteroids compared to medium-dose corticosteroids in patients with pulmonary sarcoidosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    • Prednisolone
    • Prednisone
    France

  • Morning Versus Afternoon Pembrolizumab, Carboplatin, and Pemetrexed in Adults With Stage IV Non-Squamous Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Pembrolizumab
    • Pemetrexed Disodium
    France
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!